Cencora (COR) Stock Forecast & Price Target

$302.32 -7.26 (-2.34%)

Closing price 07/9/2026 03:59 PM Eastern

Extended Trading

$302.42 +0.11 (+0.04%)

As of 07/9/2026 07:56 PM Eastern

Compare

Cencora - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
4

Buy
11

Based on 15 Wall Street analysts who have issued ratings for Cencora in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 4 have given a hold rating, and 11 have given a buy rating for COR.

Consensus Price Target

$367.75
21.64% Upside

According to the 15 analysts' twelve-month price targets for Cencora, the average price target is $367.75. The highest price target for COR is $440.00, while the lowest price target for COR is $285.00. The average price target represents a forecasted upside of 21.64% from the current price of $302.32.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for COR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cencora and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COR Analyst Ratings Over Time

Type	Current Forecast 7/10/25 to 7/10/26	1 Month Ago 6/10/25 to 6/10/26	3 Months Ago 4/11/25 to 4/11/26	1 Year Ago 7/10/24 to 7/10/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	9 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$367.75	$380.25	$398.17	$306.33
Forecasted Upside	21.64% Upside	35.09% Upside	24.05% Upside	3.03% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

COR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

COR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cencora Stock vs. The Competition

Type	Cencora	Medical Companies	Broader Market
Consensus Rating Score	2.73	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	21.64% Upside	649.25% Upside	14.43% Upside
News Sentiment Rating	Very Positive News See Recent COR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/30/2026	Weiss Ratings 5 of 5 stars		Downgrade	Buy (B-) ➝ Hold (C+)
6/24/2026	Bank of America 4 of 5 stars	Michael Funk 1 of 5 stars	Boost Target	Neutral	$280.00 ➝ $285.00	-0.80%
6/10/2026	Barclays 3 of 5 stars	Glen Santangelo Not Rated	Lower Target	Overweight	$425.00 ➝ $350.00	+25.38%
5/11/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$429.00 ➝ $331.00	+26.74%
5/8/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$342.00	+29.53%
5/7/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$410.00 ➝ $412.00	+59.99%
5/7/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$405.00 ➝ $355.00	+39.27%
5/7/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rodgers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$420.00 ➝ $339.00	+33.89%
4/28/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Smock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Market Perform
4/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$360.00	+12.35%
Get the Latest News and Ratings for COR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cencora and its competitors with MarketBeat's FREE daily newsletter.
3/17/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
2/10/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$417.00 ➝ $419.00	+16.41%
1/22/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Tanquilut Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Underperform ➝ Buy
11/10/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$350.00 ➝ $400.00	+10.23%
11/6/2025	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Valiquette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$340.00 ➝ $380.00	+7.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:45 AM ET.

Should I Buy Cencora Stock? COR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, July 4, 2026. Please send any questions or comments about these Cencora pros and cons to contact@marketbeat.com.

Cencora
Bull Case

Here are some ways that investors could benefit from investing in Cencora, Inc.:

The company has recently announced a share buyback plan allowing for the repurchase of $2.00 billion in shares, indicating management's belief that the stock is undervalued.
Cencora, Inc. reported a revenue increase of 3.9% compared to the same quarter last year, showcasing its growth potential in the healthcare services sector.
The current stock price is around $350, which reflects a favorable valuation compared to its historical performance and analyst price targets.
With a dividend yield of 0.8% and a payout ratio of 18.40%, Cencora, Inc. offers a steady income stream for investors while maintaining a healthy balance for reinvestment.
Analysts have a positive outlook, with a consensus EPS forecast of 17.79 for the current fiscal year, suggesting strong earnings growth ahead.

Cencora
Bear Case

Investors should be bearish about investing in Cencora, Inc. for these reasons:

The company reported earnings per share of $4.75, which missed analysts' expectations, indicating potential challenges in meeting growth targets.
Cencora's net margin is relatively low at 0.78%, which may raise concerns about profitability and operational efficiency.
Despite revenue growth, the company’s revenue of $78.36 billion fell short of consensus estimates, suggesting possible market pressures or operational hurdles.
Recent price target reductions by analysts, including a cut from $425 to $350, may signal a lack of confidence in the stock's short-term performance.
Institutional investors hold a significant majority of the stock (97.52%), which could lead to volatility if large shareholders decide to sell.

COR Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Cencora is $367.75, with a high forecast of $440.00 and a low forecast of $285.00.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cencora in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" COR shares.

According to analysts, Cencora's stock has a predicted upside of 21.64% based on their 12-month stock forecasts.

Over the previous 90 days, Cencora's stock had 2 downgrades by analysts.

Cencora has been rated by research analysts at Bank of America, Barclays, Citigroup, Morgan Stanley, Robert W. Baird, UBS Group, Weiss Ratings, Wells Fargo & Company, and William Blair in the past 90 days.

Analysts like Cencora more than other "medical" companies. The consensus rating for Cencora is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how COR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cencora Recommendations

This page (NYSE:COR) was last updated on 7/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cencora (COR) Stock Forecast & Price Target

Cencora - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

COR Analyst Ratings Over Time

COR Analyst Recommendations By Month

COR Price Targets by Month

Cencora Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cencora Stock? COR Pros and Cons Explained

Cencora
Bull Case

Cencora
Bear Case

COR Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cencora Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cencora (COR) Stock Forecast & Price Target

Cencora - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

COR Analyst Ratings Over Time

COR Analyst Recommendations By Month

COR Price Targets by Month

Cencora Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cencora Stock? COR Pros and Cons Explained

Cencora Bull Case

Cencora Bear Case

COR Forecast - Frequently Asked Questions

What is Cencora's forecast for 2026?

Should I buy or sell Cencora stock right now?

Does Cencora's stock price have much upside?

Has Cencora been downgraded by Wall Street analysts recently?

What analysts cover Cencora?

Do Wall Street analysts like Cencora more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cencora Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Cencora
Bull Case

Cencora
Bear Case